Why Do Genetic and Lab Findings Often Mismatch in VTE Anticoagulant Defect Diagnosis?
Journal of Thrombosis and Haemostasis (JTH) shared an insightful post on LinkedIn:
“Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism.
In VTE patients, genotype-phenotype concordance for natural anticoagulant defects is far from absolute.
This study reveals that genetic variants may present with normal plasma activity, while reduced activity can occur without detectable variants – underscoring the diagnostic limitations of relying solely on either approach.”
Read the paper here.
Article:ย Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism
Authors: Christine Van Laer, Marthe Vanrenterghem, Marc Jacquemin, Andreas Verstraete, Sarissa Baert, Cyrielle Kint, Mirjam Kruijt, Renee Ruhaak, Veerle Labarque, Thomas Vanassche, Peter Verhamme, Kathelijne peerlinck, Kathleen Freson
Stay updated with Hemostasis Today.
-
Aug 17, 2025, 15:26EAHAD 2026 Dublin: Join Leading Haemophilia Experts for Research Insights and Networking
-
Aug 17, 2025, 15:03Why Do Genetic and Lab Findings Often Mismatch in VTE Anticoagulant Defect Diagnosis?
-
Aug 17, 2025, 12:18Omar Adwan on G6PD Deficiency: Protecting Red Blood Cells from Oxidative Stress
-
Aug 17, 2025, 08:00Eddy Gutierrez Shares Insights on Thrombocytopenia Management in the ICU
-
Aug 17, 2025, 07:14National Research Blueprint Evolves into Bleeding Disorders Research Collaborative
-
Aug 17, 2025, 11:34DAPT After PCI: Sex-Specific Strategies Unveiled
-
Aug 17, 2025, 08:21Eva Kempers: Menstrual Blood Loss and Quality of Life in Antiplatelet Therapy
-
Aug 17, 2025, 07:44CDC/FDA Data Shows 112,000% More Brain Clots After mRNA Shots
-
Aug 16, 2025, 16:33RPTH Journal: Dietmar Fries and Colleagues Explore Impact of Long-Distance Trail Running on Blood Markers
-
Aug 16, 2025, 16:15Josepha Clara Sedzro: First Cryo-EM Structure of the Coagulation Initiation Complex
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
-
Aug 15, 2025, 03:44Call for Global Action on Bleeding Disorders from Baumann, Christoforou and Klamroth
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada